Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene
Clinical trial NCT03448081 · COMPLETED
Trial details
- NCT number
- NCT03448081
- Sponsor
- Sienna Biopharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-12
- Primary completion
- 2018-11-21
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.